News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Xlife Sciences AG Announces Strategic Merger Between palleos healthcare GmbH and OCT Clinical GmbH
Xlife Sciences AG announces strategic merger between palleos healthcare GmbH and OCT Clinical GmbH, creating a leading company in clinical research with comprehensive global services -
-
-
COMMUNIQUÉ DE PRESSE
Xlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the 2023 Valuation Report
Xlife Sciences AG reports strong portfolio growth and strategic advances in the 2023 Valuation Report by independent consulting firm CYLAD Experts. Portfolio valued at CHF 611.7-747.8 million -